Occudo Quantitative Strategies LP Athenex, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.36 - $2.94 $7,448 - $16,102
-5,477 Reduced 3.48%
151,987 $207,000
Q3 2021

Nov 15, 2021
BUY
$2.97 - $4.84 $157,819 - $257,187
53,138 Added 50.93%
157,464 $474,000
Q2 2021

Aug 16, 2021
SELL
$3.71 - $5.13 $812,527 - $1.12 Million
-219,010 Reduced 67.73%
104,326 $482,000
Q1 2021

May 14, 2021
BUY
$4.08 - $14.75 $1.32 Million - $4.77 Million
323,336 New
323,336 $1.39 Million

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email